Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 1Barrett Esophagus 1

Interventions

Specimen Handling 2Endoscopy, Digestive System 2Endoscopy 2Biopsy 2Aspirin 2polyphenon E 1obeticholic acid 1Ursodeoxycholic Acid 1Radiofrequency Ablation 1Metformin 1Itraconazole 1Genetic Linkage 1Gastroscopy 1Esomeprazole 1Erlotinib Hydrochloride 1Comparative Genomic Hybridization 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Barrett Esophagus × Ursodeoxycholic Acid × Clear all
NCT01097304 2017-12-19

Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia

National Cancer Institute (NCI)

Phase 2 Completed
36 enrolled 10 charts
Gastrointestinal

Barrett Esophagus, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡